Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology
Por um escritor misterioso
Descrição
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label
Graves Disease: Practice Essentials, Pathophysiology, Epidemiology
Long-term statins administration exacerbates diabetic nephropathy
Efficacy and safety of osilodrostat in patients with Cushing's
PDF) Understanding Pathogenesis Intersects With Effective
Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and
Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO
Current concepts regarding Graves' orbitopathy - Bartalena - 2022
Effect of dapagliflozin on the rate of decline in kidney function
Proposal for Standardization of Primary and Secondary Outcomes in
de
por adulto (o preço varia de acordo com o tamanho do grupo)
